269 related articles for article (PubMed ID: 30701900)
21. [Comparison of plasma exchange (PEX) vs. double filtration plasmapheresis (DFPP) with or without steroid administration in a case of MPO-ANCA-positive immune complex type crescentic glomerulonephritis].
Ito C; Ando Y; Akimoto T; Kusano E; Asano Y
Nihon Jinzo Gakkai Shi; 2000 Jul; 42(5):374-80. PubMed ID: 10998918
[TBL] [Abstract][Full Text] [Related]
22. Coagulation abnormalities in serial double-filtration plasmapheresis.
Yeh JH; Chiu HC
J Clin Apher; 2001; 16(3):139-42. PubMed ID: 11746541
[TBL] [Abstract][Full Text] [Related]
23. Hemostasis management and therapeutic plasma exchange: Results of a practice survey.
Zantek ND; Boral LI; Li Y; Yamada C; Svensson AM; Crane JE; Smith RE; Pagano MB; Rollins-Raval MA; Schmidt AE; Wong ECC; Wu Y
J Clin Apher; 2018 Oct; 33(5):604-610. PubMed ID: 30207610
[TBL] [Abstract][Full Text] [Related]
24. Effect of therapeutic plasma exchange on coagulation parameters in patients on warfarin.
Zantek ND; Morgan S; Zantek PF; Mair DC; Bowman RJ; Aysola A
J Clin Apher; 2014 Apr; 29(2):75-82. PubMed ID: 24000079
[TBL] [Abstract][Full Text] [Related]
25. How to improve clotting factors depletion in double-filtration plasmapheresis.
Naciri Bennani H; Marlu R; Terrec F; Motte L; Seyve L; Chevallier E; Malvezzi P; Jouve T; Rostaing L; Noble J
J Clin Apher; 2021 Oct; 36(5):766-774. PubMed ID: 34339059
[TBL] [Abstract][Full Text] [Related]
26. Double filtration plasmapheresis: Review of current clinical applications.
Hirano R; Namazuda K; Hirata N
Ther Apher Dial; 2021 Apr; 25(2):145-151. PubMed ID: 32558286
[TBL] [Abstract][Full Text] [Related]
27. Plasma exchange versus double filtration plasmapheresis in the treatment of Guillain-Barré syndrome.
Lyu RK; Chen WH; Hsieh ST
Ther Apher; 2002 Apr; 6(2):163-6. PubMed ID: 11982959
[TBL] [Abstract][Full Text] [Related]
28. Optimizing management of replacement fluids for therapeutic plasma exchange: Use of an automated mathematical model to predict post-procedure fibrinogen and antithrombin levels in high-risk patients.
Zhang R; Dahl AB; Marchant B; Jackups RR; Karnes HE; Shah P; Dynis M; Thibodeaux SR; Despotis GJ
J Clin Apher; 2020 Jan; 35(1):41-49. PubMed ID: 31713919
[TBL] [Abstract][Full Text] [Related]
29. THERAPEUTIC PLASMA EXCHANGE AND DOUBLE FILTRATION PLASMAPHERESIS IN SEVERE NEUROIMMUNE DISORDERS.
Roman-Filip C; Catană MG; Bereanu A; Lăzăroae A; Gligor F; Sava M
Acta Clin Croat; 2019 Dec; 58(4):621-626. PubMed ID: 32595246
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for early hemorrhagic and thrombotic complications after kidney transplantation.
Pawlicki J; Cierpka L; Król R; Ziaja J
Transplant Proc; 2011 Oct; 43(8):3013-7. PubMed ID: 21996213
[TBL] [Abstract][Full Text] [Related]
31. Ability to remove immunoglobulins and antiganglioside antibodies by double filtration plasmapheresis in Guillain-Barré syndrome: is it equivalent to plasma exchange?
Tagawa Y; Yuki N; Hirata K
Ther Apher; 1997 Nov; 1(4):336-9. PubMed ID: 10225726
[TBL] [Abstract][Full Text] [Related]
32. The effects of double-filtration plasmapheresis on coagulation profiles and the risk of bleeding.
Pan SY; Tao-Min Huang T; Lin YC; Liu HT; Chou SC; Lee CY; Chen CC; Fu CH; Chao CC; Wu VC
J Formos Med Assoc; 2024 Feb; ():. PubMed ID: 38395630
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic Plasma Exchange in Pediatric Renal Transplantation Experience of One Decade and 389 Sessions.
Runowski D; Prokurat S; Rubik J; Grenda R
Transplant Proc; 2018 Dec; 50(10):3483-3486. PubMed ID: 30577225
[TBL] [Abstract][Full Text] [Related]
34. Asparaginase-associated concurrence of hyperlipidemia, hyperglobulinemia, and thrombocytosis was successfully treated by centrifuge/membrane hybrid double-filtration plasmapheresis.
Wang T; Xu B; Fan R; Liu Z; Gong D
J Clin Lipidol; 2016; 10(3):646-9. PubMed ID: 27206953
[TBL] [Abstract][Full Text] [Related]
35. Optimal Settings for Double Filtration Plasmapheresis With Targeted Removal Rate of Preexisting Antibody in Antibody-Incompatible Kidney Transplant.
Iwami D; Miura M; Chiba Y; Ota M; Matsumoto T; Hotta K; Sasaki H; Hirose T; Harada H; Shinohara N
Transplant Proc; 2018 Dec; 50(10):3478-3482. PubMed ID: 30577224
[TBL] [Abstract][Full Text] [Related]
36. Double filtration plasmapheresis can decrease factor XIII Activity.
Hanafusa N; Kondo Y; Suzuki M; Nakao A; Noiri E; Fujita T
Ther Apher Dial; 2007 Jun; 11(3):165-70. PubMed ID: 17497996
[TBL] [Abstract][Full Text] [Related]
37. Effects of therapeutic plasma exchange on anticoagulants in patients receiving therapeutic anticoagulation: a systematic review.
Hodulik KL; Root AG; Ledbetter LS; Onwuemene OA
Transfusion; 2019 May; 59(5):1870-1879. PubMed ID: 30762882
[TBL] [Abstract][Full Text] [Related]
38. Fibrinogen reduction and bleeding complications in plasma exchange, immunoadsorption and a combination of the two.
Zöllner S; Pablik E; Druml W; Derfler K; Rees A; Biesenbach P
Blood Purif; 2014; 38(2):160-6. PubMed ID: 25501972
[TBL] [Abstract][Full Text] [Related]
39. More selective removal of myeloperoxidase-anti-neutrophil cytoplasmic antibody from the circulation of patients with vasculitides using a novel double-filtration plasmapheresis therapy.
Gong D; Ji D; Xu B; Liu Z
Ther Apher Dial; 2013 Feb; 17(1):93-8. PubMed ID: 23379500
[TBL] [Abstract][Full Text] [Related]
40. Experience of double filtration plasmapheresis in the treatment of Guillain-Barré syndrome.
Chen WH; Yeh JH; Chiu HC
J Clin Apher; 1999; 14(3):126-9. PubMed ID: 10540367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
